| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Rituximab - Effective 11/1/2017 (CP.PHAR.260) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Naloxone (Evzio) (CP.PMN.139) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Influenza Testing | |
| Meridian Illinois Medicaid Clinical | Aflibercept (Eylea) (CP.PHAR.184) | |
| Meridian Illinois Medicaid Clinical | Belantamab Mafodotin (Blenrep) (CP.PHAR.469) | |
| Meridian Illinois Medicaid Clinical | Ciltacabtagene Autoleucel (CP.PHAR.533) | |
| Meridian Illinois Medicaid Clinical | Copanlisib (Aliqopa) (CP.PHAR.357) | |
| Meridian Illinois Medicaid Clinical | Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (CP.PHAR.220) | |
| Meridian Illinois Medicaid Clinical | Iloperidone (Fanapt) (CP.PMN.32) | |
| Meridian Illinois Medicaid Clinical | Infigratinib (Truseltiq) (CP.PHAR.547) | |